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ABSTRACT
In strains of Neisseria gonorrhoeae harboring the mtr and penB determinants that decrease permeation of antibiotics into the
periplasm, mutation or deletion of the PilQ secretin of type IV pili increases resistance to penicillin by 3-fold, indicating a role
for PilQ in antibiotic permeation. In this study, we examined spontaneously arising mutants with decreased susceptibility to
penicillin. One class of mutants had a phenotype indistinguishable from that of a previously characterized pilQ2 mutation that
interfered with the formation of SDS-resistant PilQ multimers. A second class of mutants contained frameshift mutations in
genes upstream of pilQ in the pilMNOPQ operon that increased resistance to levels similar to those of the pilQ2 mutation. In-
frame deletions of these genes were constructed, but only the frameshift mutations increased antibiotic resistance, suggesting
that the mutations had polar effects on PilQ. Consistent with this result, titration of wild-type PilQ levels revealed a direct corre-
lation between resistance and expression levels of PilQ. To determine which form of PilQ, the monomer or the multimer, was
responsible for antibiotic permeation, we manipulated and quantified these forms in different mutants. Deletion of PilW, which
is responsible for the maturation of PilQ into SDS-resistant multimers, had no effect on resistance. Moreover, Western blot anal-
ysis revealed that while SDS-resistant multimer levels were decreased by 26% in frameshift mutants, the levels of PilQ mono-
mers were decreased by 48%. These data suggest that immature, SDS-labile complexes, not mature, SDS-resistant PilQ com-
plexes, serve as the route of entry of antibiotics into the periplasm.
IMPORTANCE
The capacity of antibiotics to reach their target is crucial for their activity. In Neisseria gonorrhoeae, the PilQ secretin of type IV
pili plays an important role in antibiotic influx when diffusion of antibiotics through porins is limited (e.g., in most resistant
strains). On Western blots, PilQ exists both as a mature higher-order multimer and an immature, SDS-labile monomer. In this
study, we examined spontaneously arising mutations in PilQ and in the genes upstream of PilQ in the pilMNOPQ operon that
increase resistance to penicillin. We provide evidence that PilQ monomers associate by mass action to form immature multimers
and that these complexes likely mediate the diffusion of antibiotics across the outer membrane.
Gonorrhea, the sexually transmitted infection (STI) caused byNeisseria gonorrhoeae, is the most prevalent STI worldwide,
with an estimated 106 million infections per year (1). There is no
vaccine against N. gonorrhoeae, and because patients do not de-
velop immunological memory, there is a high rate of reinfection
(2). Because of the absence of an adequate immune response,
antibiotic therapy is the standard of care for curing gonorrheal
infections, but antibiotic resistance has rendered many of the
available therapeutics ineffective. Historically, gonorrhea has
been treated with penicillin, tetracycline, spectinomycin, or fluo-
roquinolones, but these antibiotics were discontinued because of
widespread resistance (3, 4). The current CDC recommendation
for the treatment of gonorrhea in the United States is dual therapy
with ceftriaxone and azithromycin or doxycycline; however,
strains resistant to each of these antibiotics have been reported
(5–8), eliciting concern that we are ushering in an era of untreat-
able gonorrhea (9).
The gonococcus develops resistance to penicillin either through
the acquisition of a plasmid encoding a TEM-1-like -lactamase or
by acquiring multiple chromosomal mutations that incrementally
increase resistance in a stepwise manner (10). Because N. gonor-
rhoeae is naturally competent, chromosomal resistance alleles can
be transferred from a penicillin-resistant strain to a susceptible
strain by transformation and homologous recombination (11).
Four known resistance determinants (and a fifth, unknown deter-
minant) contribute to penicillin resistance; three of these deter-
minants (penA, mtr, and penB) have been characterized exten-
sively and have well-documented effects on resistance, while the
contributions of the remaining determinants (ponA and the un-
known determinant) are more complicated or have not been iden-
tified molecularly (12). Each determinant by itself increases resis-
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tance by only 2- to 8-fold; however, the combination of all five
determinants results in a 400-fold increase in resistance to peni-
cillin and subsequent treatment failure (13).
The first resistance determinant acquired by a susceptible
strain is the penA allele, which encodes altered forms of penicillin-
binding protein 2 (PBP 2), the lethal target of penicillin, with a
decreased rate of acylation by penicillin (14, 15). While the penA
alleles that contribute to high-level penicillin resistance have only
4 to 8 mutations, the recent emergence and spread of strains with
intermediate- and high-level resistance to ceftriaxone and ce-
fixime are due in part to the acquisition of highly mosaic alleles of
penA with up to 70 amino acid changes that result in markedly
lower rates of acylation to expanded-spectrum cephalosporins (9,
16). The second resistance determinant, mtr, encompasses muta-
tions located either in the overlapping promoter regions of mtrR
and mtrCDE or within the coding sequence of mtrR that increase
the expression of the MtrC-MtrD-MtrE efflux pump (17, 18). mtr
mutations confer only a 2-fold increase in the MIC of penicillin
but are necessary for high-level penicillin resistance in clinical
isolates (19). The third resistance determinant, penB, encodes mu-
tations in the outer membrane porin, PorB1B. These mutations
decrease the influx of penicillin (and other antibiotics) through
porin channels, thereby reducing the concentration of the antibi-
otic in the periplasm (20–22). Surprisingly, penB mutations are
phenotypically silent (i.e., they confer no resistance) unless there
is a coresident mtr mutation (22).
Given the importance of antibiotic resistance in gonococci, it is
important to understand all aspects of antibiotic action in the
organism. To this end, we have described a spontaneously occur-
ring mutation in PilQ (pilQ2) that increases resistance to penicil-
lin and other antibiotics by 2- to 3-fold in a strain (FA19 penA
mtrR penB) harboring the first three resistance determinants (12,
23). PilQ is a major component of the outer membrane and is
essential for type IV pilus (tfp) function, including twitching mo-
tility, uptake of extracellular DNA, and cell attachment and inva-
sion (24–26). The pilus is composed of a polymer of pilin subunits
that extends and retracts through a pore in the outer membrane
formed by a multimeric PilQ complex (27). When gonococcal
membranes are analyzed by SDS-PAGE and Western blotting,
PilQ is found in two forms: a mature, SDS-resistant multimer that
runs near the top of the running gel and an immature, SDS-labile
form that runs at the size of a monomer (28, 29). The mutation in
the pilQ2 allele (E666K) prevents maturation of the complex so
that all of the PilQ subunits migrate as a monomer on SDS-PAGE;
this strain also exhibits a nonpiliated colony morphology and a
50-fold decrease in transformation efficiency (23). These data
were consistent with a model in which the mature, SDS-resistant
multimer functions as a pore through which antibiotics and small
molecules diffuse into the periplasm, with the pilQ2 mutation
preventing the formation of the mature oligomer and leading to
an increase in antibiotic resistance.
In this study, we further investigated the influence of PilQ on
antibiotic permeability. We isolated a number of spontaneously
arising mutants displaying a nonpiliated colony morphology and
reduced susceptibility to penicillin. Some of these mutants con-
tained amino acid substitutions in the C-terminal portion of PilQ
and had a phenotype identical to that of the pilQ2 mutant, i.e., loss
of the SDS-resistant multimer on SDS-PAGE. We also isolated
resistant mutants with near-normal levels of the PilQ multimer
but with frameshift mutations in the genes upstream of pilQ in the
pilMNOPQ operon. The effects of these frameshift mutations on
resistance were due to polar effects on PilQ, however, as in-frame
deletions of the pilMNOP genes had no effect on penicillin resis-
tance. Further examination of these mutants and strains by ma-
nipulating either the levels of PilQ expression or the formation of
stable SDS-resistant multimers led us to develop a model in which
PilQ monomers associate in the outer membrane to form imma-
ture, SDS-labile complexes that act as channels for antibiotics. In
this model, the frameshift mutants result in marked reduction of
PilQ monomers, thereby decreasing the association of these sub-
units into immature oligomers that allow antibiotics to diffuse
into the periplasm and increasing antibiotic resistance.
MATERIALS AND METHODS
Bacterial strains. N. gonorrhoeae strains FA19 (a penicillin-susceptible
laboratory strain; penicillin MIC  0.01 g/ml) was kindly provided by
Fred Sparling, University of North Carolina at Chapel Hill (UNC) (30).
PR100 (FA19 penA mtrR penB) and SZ3 (RM11.2 penA mtrR penB), both
of which harbor three penicillin resistance determinants from FA6140,
have been described previously (12, 23). RM11.2 (FA1090 recA6) has the
recA gene under regulation by the lac operator/promoter (31). These
strains and others used in this study are listed in Table 1.
We used SZ3 and PR100 interchangeably in this study. When the three
resistance determinants were transferred into SZ3 and PR100, the result-
ing strains had nearly identical properties. Because the pilE allele can affect
transformation efficiency, SZ3 was initially used in transformation effi-
ciency experiments to prevent recA-dependent changes in pilE (23), but
PR100 was the parental strain in later experiments examining the com-
plementation of pilM, pilN, pilO, and pilP in-frame deletions. The only
difference we observed between the two strains was that the penicillin
MIC for PR100 was slightly higher (0.75 g/ml) than that for SZ3 (0.5
g/ml); introduction of the various mutations described here resulted in
similar increases in the MIC of penicillin regardless of whether the paren-
tal strain was PR100 or SZ3.
TABLE 1 N. gonorrhoeae strains used in this study
Straina Description Reference
FA19 Penicillin-sensitive clinical isolate 30
PR100 FA19 penA mtrR penB 12
RM11.2 FA1090 containing recA under IPTG regulation 31
SZ3 RM11.2 penA mtrR penB 23
PR100 pilQ2 PR100 containing a PilQ G666L mutation 23
PR100 pilW::kan PR100 containing pilW disrupted with a Kanr cassette This study
PR100 proAB-pilW pKH-pilW PR100 containing two IPTG-inducible copies of pilW This study
PR100 pKH35-pilQHA PR100 containing an IPTG-inducible copy of pilQ This study
PR100 pKH35-pilQHA pilQ:: PR100 pKH35-pilQHA with a disrupted endogenous copy of pilQ This study
a PilQ point mutants and the frameshift and in-frame pilM, pilN, pilO, and pilP mutants not listed here were constructed in either PR100 or SZ3, as described in the text.
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Bacterial media, growth conditions, and MIC determinations. N.
gonorrhoeae strains were grown at 37°C in a humidified 4% CO2 incubator
on GC medium base (GCB) agar plates fortified with supplements I and II
(32). Escherichia coli strains were grown on Luria-Bertani plates or in 2
YT medium, as described previously (12). For cloning in E. coli, genes
were cloned into pUC18us (pUC18 containing the 10-bp gonococcal up-
take sequence, GCCGTCTGAA [33]) or pGCC4, a complementation vec-
tor that puts genes under the control of the isopropyl--D-thiogalactoside
(IPTG)-inducible lac promoter/operator and allows recombination into
the silent intergenic region between lctP and aspC (34) in N. gonorrhoeae.
E. coli transformants were selected on either 100 g/ml carbenicillin
(pUC18us) or 350 g/ml erythromycin (pGCC4). Sequence-verified
plasmids were used to transform gonococci using the protocol outlined
below.
MICs were determined by the spot method, as described previously
(12). Briefly, cells were resuspended at a density of 1  107 cells/ml, and 5
l (50,000 colonies) was spotted onto GCB agar plates containing increas-
ing concentrations of the indicated antibiotics. The MIC was defined as
the lowest concentration at which no more than 5 colonies grew following
incubation for 24 h. MICs were determined for multiple transformants
and represent the averages and standard errors of the mean of at least three
independent experiments.
Transformations and transformation efficiency assays. Transfor-
mations were carried out essentially as described previously (12). Because
pilQ mutations and pilM, pilN, pilO, and pilP frameshift mutations con-
ferred resistance to penicillin, these transformants were selected on peni-
cillin plates. For pilM, pilN, pilO, and pilP in-frame constructs that did not
confer increased penicillin resistance, the transformation mixture was
plated on GCB plates with no selection, and colonies with a nonpiliated
morphology were screened by colony PCR using gene-specific primers.
All strains were verified by PCR amplification of the appropriate regions
and sequencing the resulting DNA fragments. Transformants of pGCC4
plasmids into PR100 were selected on 6 g/ml erythromycin. Because
many of the constructs rendered the recipient strain nontransformable
upon recombination, it was necessary to transform cells with the comple-
mentation vector first, followed by transformation of the mutant con-
struct.
Quantification of transformation efficiency was carried out exactly as
described by Zhao et al. (23). IPTG was added to GCB (GCB with
supplements I and II, 10 mM MgCl2, and 20 mM sodium bicarbonate) at
1 mM for transformations in SZ3 to induce expression of recA (23).
Isolation of spontaneously arising penicillin-resistant clones. To
identify spontaneously arising mutations conferring resistance to penicil-
lin, piliated PR100 or SZ3 cells were prepared as described for the trans-
formation protocol, except that cells were plated directly (without addi-
tion of DNA) on GCB agar plates containing concentrations of penicillin
just above their respective MICs (0.75 and 0.5 g/ml, respectively). Spon-
taneously arising penicillin-resistant clones, all of which were nonpiliated
by colony morphology, were passaged onto fresh selective media for fur-
ther analysis. A total of 615 clones were isolated and characterized.
All of the clones were analyzed by Western blotting with anti-PilQ
antibody as described below. Those colonies that showed a phenotype
similar to that of a pilQ2 mutant (i.e., loss of the SDS-resistant oligomer)
were prepared for colony PCR with pilQ-specific primers. Briefly, cells
were transferred to 25 l water, the mixture was boiled for 5 min, and 5 l
of the cleared lysate was amplified with either Pfu or Taq polymerase. The
PCR products were sequenced directly at the UNC sequencing facility. For
resistant clones that showed a PilQ phenotype similar to that of the wild
type, the genes upstream of pilQ (pilMNOP) were amplified and se-
quenced.
Scanning electron microscopy (SEM). SZ3 and three spontaneously
arising class 1 pilQ mutants of SZ3 (G668S, a mutant with a 7-amino-acid
[7-aa] insertion at position 631, and E712K) were grown to mid-log phase
in GCB broth, and 500 l of the suspension was pelleted via centrifuga-
tion. The cells were resuspended in 500 l of 3% glutaraldehyde, 0.15 M
sodium phosphate buffer (pH 7.4); fixed at room temperature for 30 min;
and stored at 4°C. The fixed cell suspension was then applied to 12-mm
round poly-L-lysine-coated coverslips and incubated for 2 h at room tem-
perature (RT) in a humid environment. After washing the coverslips three
times with 0.15 M sodium phosphate buffer, pH 7.4, they were dehydrated
with increasing concentrations of ethanol (30%, 50%, 75%, and 100%).
The dehydrated coverslips were dried in a Samidri-795 critical-point drier
with carbon dioxide as the transitional solvent (Tousimis Research Cor-
poration, Rockville, MD). The coverslips were mounted on 13-mm alu-
minum stubs and sputter coated with 10 nm of a gold-palladium alloy
(60% Au-40% Pd; Hummer X sputter coater; Anatech, Ltd., Alexandria,
VA). The bacterial cells were observed using a Zeiss Supra 25 field emis-
sion scanning electron microscope operating at 5 kV, with a 5-mm work-
ing distance and a 10-m aperture (Carl Zeiss SMT Inc., Peabody, MA).
Construction of pilM, pilN, pilO, and pilP frameshift and in-frame
deletion mutant clones. The pilM, pilN, pilO, and pilP genes were ampli-
fied from FA19 and cloned into pUC18us. Endogenous ClaI, BclI, and
BsmI sites in pilM, pilN, and pilP, respectively, were eliminated by digest-
ing with the specified endonuclease, filling in with Klenow fragment, and
religating. For pilO, an XbaI site was introduced via Quik-Change mu-
tagenesis (Agilent Technologies, Santa Clara, CA), digested with XbaI,
filled in, and religated. All plasmids harboring frameshift mutations in
pilM, pilN, pilO, and pilP were sequenced to confirm that the correct
mutations were incorporated, and these plasmids were used to transform
PR100 and SZ3 to decreased penicillin susceptibility. PCR amplification
and digestion with the endonucleases listed above were used to confirm
recombination of the mutant gene.
In-frame deletions in pilM, pilN, pilO, and pilP were created by am-
plifying 5= and 3= fragments of the gene of interest and cloning them into
pUC18us. While the external primers contained different restriction sites
at their 5= ends, the internal primers contained a common restriction site
that facilitated construction of the in-frame deletion. Each gene retained
some 5= and 3= sequence, but approximately two-thirds of the interior
sequence was deleted. Specifically, the pilM in-frame deletion deleted
codons 88 to 317 (bp 262 to 951), the pilN construct deleted codons 31 to
155 (bp 91 to 465), pilO was missing codons 26 to 170 (bp 76 to 510), and
pilP was missing codons 31 to 144 (bp 91 to 432). Each deletion construct
also contained 300 bp of sequence both upstream and downstream of
the deletion to facilitate successful recombination with chromosomal
DNA. The in-frame deletion constructs were used to transform PR100,
and because no selectable marker was transferred to the chromosome,
colonies with a nonpiliated morphology were chosen for PCR screening to
identify correct transformants. In-frame deletion clones were verified by
sequencing and Western blotting.
Gel filtration. Gel filtration was performed as previously described
(23). Briefly, FA19 cells were grown in liquid culture, the cells were pel-
leted and lysed with an Emulsiflex-C5 homogenizer (Avestin, Ottawa,
Canada), and the lysate was centrifuged at 100,000  g to isolate the
membranes. PilQ proteins were extracted from the membranes via
Dounce homogenization in 30 mM Tris, 1.6 mM NaCl, 2 mM EDTA, 2%
SB-10 [3-(decyldimethylammonio)propanesulfonate], pH 8.0, and sub-
mitted to gel filtration on a Sephacryl S-500 column in 20 mM Tris, 500
mM NaCl, 1 mM EDTA, 1.2% SB-10, pH 8. The eluted fractions were
analyzed by Western blotting with PilQ antibody and quantified using
QuantityOne software (Bio-Rad, Hercules, CA).
Overexpression of PilQ. Expression of full-length pilQ in E. coli is
lethal; therefore, the 5= and 3= ends of pilQ were introduced into the
recipient strain in a stepwise manner. The 5= end of pilQ (including its
ribosomal binding site) through bp 1180 was amplified as a PacI-SacI
fragment and ligated into pKH35, a complementation vector similar to
pGCC4, except that it contains a more extensive multiple cloning site and
a chloramphenicol acetyltransferase gene for selection. This construct was
transformed into N. gonorrhoeae strain FA19, and recombinants were
selected on 0.6 g/ml chloramphenicol. The 3= end of pilQ (bp 671 to
2196) was amplified using a 5= primer containing a HindIII site and a 3=
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primer containing an XbaI site and a hemagglutinin (HA) tag. A 400-bp
fragment from pKH35 downstream of the multiple cloning site was am-
plified using primers that added a 5=XbaI site and a 3=BamHI site, and this
fragment was cloned into the vector pUC18us in a three-way ligation with
the 3= fragment of pilQ. To allow selection of gonococcal transformants, a
kanamycin resistance cassette was introduced into the XbaI site at the 3=
end of the pilQ sequence. This plasmid was then transformed into the
FA19 strain that had been previously transformed with the plasmid con-
taining the 5= pilQ sequence.
Because strain PR100 has reduced transformation efficiency with
pKH35 plasmids relative to FA19, the entire IPTG-inducible pilQ com-
plementation locus was constructed in FA19, and genomic DNA was pre-
pared from this strain and used to transform PR100 to give PR100
pKH35-pilQHA, which contains two copies of pilQ. This strain was then
transformed with a construct that disrupted the endogenous copy of pilQ
via the insertion of a spectinomycin resistance cassette (35). This strain,
PR100 pKH35-pilQHA pilQ::, contained only an IPTG-inducible copy
of pilQ.
pilW knockout and overexpression. An insertionally inactivated mu-
tant of pilW was created by cloning pilW into pUC18us, digesting with
BstXI and HpaI, filling in with T4 DNA polymerase, and ligating in a
kanamycin resistance cassette. The kanamycin phosphotransferase gene
was cloned in the same direction as the pilW gene. PR100 was transformed
with the pUC18us-pilW::kan plasmid, and transformants were selected on
GCB agar containing 50 g/ml kanamycin. For overexpression of PilW,
we utilized a plasmid (pUC18K-proAB-Q19e) containing the lacIq gene
from pMJR200, the tac promoter/operator and multiple cloning site from
pTTQ18, the erythromycin resistance gene, and flanking sequence from
the gonococcal proAB operon to facilitate homologous transformation.
pilW was cloned under the transcriptional control of the tac promoter,
and the resulting plasmid was used to transform PR100 to erythromycin
resistance (selected on 4 g/ml erythromycin). To further increase PilW
expression, pilW was cloned into pKH35, and this construct was used to
transform the preceding strain. The different selectable markers allowed
both expression constructs to be introduced into the same cell. Expression
of PilW was induced by 0.1 to 10 mM IPTG.
SDS-PAGE and Western blotting. Cells were swabbed from GCB
plates, resuspended in GCB, and diluted to an optical density at 560 nm
(OD560) of 0.18 (1  10
8 cells/ml). An aliquot (1 ml) of the diluted cells
was centrifuged at 8,000 rpm for 3 min to pellet the cells, the supernatants
were aspirated, and the pellets were resuspended in 100 to 200 l of SDS-
PAGE loading buffer. The samples were heated in a boiling water bath for
5 min, and 5 to 10 l was loaded onto SDS-polyacrylamide gels (8% for
PilQ and 12% for all other proteins) and separated by electrophoresis. The
proteins were then transferred onto nitrocellulose membranes overnight
in 25 mM Tris, 192 mM glycine, 10% methanol, and 0.02% SDS at 4°C.
The lower methanol concentration and presence of SDS appeared to in-
crease the efficiency of transfer of the PilQ oligomer (23). Following trans-
fer, the membrane was rinsed in phosphate-buffered saline containing
0.1% Tween 20 (PBS-T), followed by blocking with 5% nonfat dry milk in
PBS-T for 1 h at RT, and then probed with a 1:10,000 dilution of a rabbit
PilM, PilN, PilO, PilP, or PilQ polyclonal antibody for 2 h at RT. Anti-PilP
and PilQ antibodies were made by Charles E. Wilde III, Indiana University
School of Medicine, and obtained from Hank Seifert, Northwestern Uni-
versity. PilM, PilN, and PilO antibodies were produced by Covance
(Princeton, NJ) from the purified recombinant proteins. The membrane
was washed three times with PBS-T and incubated for another hour with
horseradish peroxidase (HRP)-conjugated mouse anti-rabbit secondary
antibody (Amersham Biosciences, Piscataway, NJ). After washing the
membrane three times with PBS-T, the membrane was treated with Su-
perSignal West Pico (Pierce Chemical, Rockford, IL) for 5 min at RT, and
expression of Pil protein bands was visualized by exposing the membrane
to X-ray film (Kodak).
For quantitative Western blots, 4 to 6 independent cell lysates from
PR100 and PR100 pilMFS (where pilMFS represents the pilM frameshift
mutation) were prepared as described above, and 15 l of each sample was
loaded onto an SDS-8% PAGE gel and run at 80 V for approximately 150
min. Proteins were transferred to low-fluorescence polyvinylidene diflu-
oride (LF-PVDF) membranes with a semidry transfer apparatus at 155
mA for 45 min in the presence of the transfer buffer described above. The
membranes were blocked in PBS-T containing 5% nonfat dry milk and
incubated with primary antibody overnight at 4°C. The membranes were
washed 3 times in PBS-T and incubated with an anti-rabbit Cy3-conju-
gated secondary antibody (GE Healthcare, Piscataway, NJ) for 2 h. The
blots were washed twice with PBS-T and once with PBS before imaging on
a Typhoon 9400 imager (GE Healthcare). PilQ and PBP 1 bands were
quantified using ImageQuant software.
For statistical analyses, the mean densitometry values for the PilQ
multimer and monomer were set at 100% for PR100 for each blot, with
the levels of each lane of PR100 calculated individually based on the
mean (to provide an indication of variance between the same samples).
The levels of multimer and monomer from PR100 pilMFS were then
calculated as a percentage of the mean values for the respective bands
from PR100. Three separate Western blots containing 4 to 6 indepen-
dent samples from each strain were analyzed, with the values calcu-
lated separately for each blot (to account for differences in arbitrary
densitometry numbers). This resulted in 10 to 13 independent deter-
minations for the two strains. Statistical significance was determined
by a one-way analysis of variance (ANOVA) with multiple compari-
sons in GraphPad Prism (San Diego, CA).
RESULTS
Phenotypic identification of spontaneously arising penicillin-
resistant clones. We have shown previously that a spontaneously
arising mutation in pilQ, pilQ-E666K (the E-to-K change at position
666 encoded by pilQ; also referred to as pilQ2), increases resistance to
penicillin and other antibiotics by 2- to 3-fold, provided that the
strain also harbors the mtrR and penB resistance determinants (23)
that collaborate to decrease permeation through the outer membrane
porin (22). The increase in resistance conferred by this mutation was
nearly identical to that conferred by an insertionally inactivated allele.
The pilQ2 mutation causes the PilQ secretin, which normally runs on
SDS-PAGE as both a mature, SDS-resistant multimer and an imma-
ture, SDS-labile monomer, to migrate entirely as a 72-kDa SDS-labile
monomer.
To examine in more detail how different mutations in pilQ
regulate the formation and expression of SDS-resistant PilQ oli-
gomers, we plated two intermediate-resistant strains, PR100
(FA19 penA mtrR penB [12]) and SZ3 (RM11.2 penA mtrR penB
[23]) (Table 1), on GCB plates containing concentrations of pen-
icillin slightly above the MICs of penicillin for the two strains (0.6
and 0.75 g/ml for PR100 and SZ3, respectively). Spontaneously
arising penicillin-resistant colonies were obtained with SZ3 and
PR100 at frequencies ranging from 2  10	6 to 5  10	6. These
colonies, all of which had a nonpiliated morphology, were ana-
lyzed by SDS-PAGE and Western blotting with an anti-PilQ anti-
body, which revealed three distinct classes of mutants (a represen-
tative blot is shown in Fig. 1A): (i) class 1 mutants had a phenotype
identical to that of the pilQ2 mutants, i.e., PilQ ran entirely as an
SDS-labile monomer (Fig. 1A, lanes 4, 5, and 13 from the left), (ii)
class 2 mutants appeared to be similar to the parental strain (Fig.
1A, lanes 3 and 6 to 10), and (iii) class 3 mutants had either smaller
fragments (i.e., unstable mutants) or a complete loss of pilQ (Fig.
1A, lanes 11, 12, and 14). Of the 615 mutants analyzed, 14.9% were
class 1, 69.4% were class 2, and 15.7% were class 3.
Characterization of class 1 mutants. Class 1 mutants had a
pilQ phenotype identical to that of the pilQ2 mutant; therefore, we
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amplified and sequenced the pilQ gene from each of the mutants
to identify the mutation(s) responsible for the loss of the SDS-
resistant oligomer. Sequence analysis identified 13 distinct muta-
tions (several were obtained multiple times) that clustered solely
within the C-terminal domain (aa 400 to 731) of PilQ: G441C,
D472N, R483P, A550V, A585V, A585T, G617W, 
T619, a 7-aa
insertion after I631 (I631-7aa), G668S, D709G, E712K, and
P719T. We did not identify the previously described E666K mu-
tation in pilQ2, although we did isolate a G668S mutation 2 amino
acids distant. To ensure that other potential mutations in non-
pilQ genes would not confound subsequent analyses, the mutant
pilQ genes were backcrossed into SZ3, and clean mutants were
selected for increased penicillin resistance and were verified by
sequencing.
Western blots of lysates from the 13 backcrossed mutants (Fig.
1B) revealed that PilQ from these strains migrated as an SDS-labile
monomer, although in four mutants, G688S, G441C, P719T, and
D472N, the level of the SDS-resistant oligomer was markedly re-
duced but not eliminated. To determine if the mutations inter-
fered with the transport of PilQ to the outer membrane, we iso-
lated outer membranes (36) from each of the 13 mutants and
examined PilQ expression by Western blotting. In each case, PilQ
was present and showed the same banding pattern as in Fig. 1B
(data not shown). Therefore, these mutant PilQ variants, much
like pilQ2, are transported to the outer membrane but are unable
to mature into SDS-resistant multimers.
The effects of the different pilQ mutations on penicillin resis-
tance and transformation efficiency were also determined. All of
the mutant pilQ alleles increased the MIC of penicillin by 2.5- to
3-fold, the same level as the previously identified pilQ2 mutation
(Fig. 2A). Increased MIC values were also observed for several
other antibiotics, including ceftriaxone, vancomycin, and rifam-
pin (data not shown). Although each mutation conferred nearly
identical increases in the MIC of penicillin, their effects on trans-
formation competence were much more varied. Four of the mu-
tations (G617W, I631-7aa, R483P, and 
T619) completely ab-
lated transformation, five others (G441C, A550V, A585V, G668S,
and P719T) had transformation efficiencies identical to the paren-
tal strain, and the remaining four mutations caused a disruption
in transformation (50- to 100-fold) similar in magnitude to that
of the pilQ2 mutation (Fig. 2B). These data reflect a lack of corre-
lation between antibiotic influx and transformation efficiency.
Although the spontaneously isolated mutants exhibited a non-








































































































FIG 1 Western blots of PilQ from spontaneously arising penicillin-resistant mutants of PR100. (A) Spontaneous mutations in PilQ were isolated by plating
PR100 cells on GCB plates containing penicillin at concentrations just above the MIC. A representative Western blot with PilQ antibody is shown for 12 out of
615 nonpiliated colonies with increased penicillin resistance. The arrows indicate bands corresponding to the SDS-resistant multimer and the SDS-labile
monomer. Three classes of mutations (class 1, pilQ2-like; class 2, normal PilQ; and class 3, PilQ deletion or truncation) were identified. The mutant classes of the
12 mutant strains are shown below the blot. (B) Thirteen different class 1 pilQ mutants were backcrossed into SZ3 and analyzed by Western blotting using a PilQ
antibody. All but four mutants showed complete loss of the SDS-resistant PilQ multimer; these four—G668S, G441C, D472N, and P719T— had a small amount
of multimer.
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mutants remained competent for transformation prompted us to
examine several of the mutants by SEM (Fig. 2C). Three mutants
with very different transformation efficiencies were chosen: (i)
G668S, which exhibited a transformation efficiency equivalent to
that of the parental strain, SZ3; (ii) the mutant with a 7-amino-
acid insertion at position 631, which had a transformation effi-
ciency below the limit of detection; and (iii) E712K, which has a
transformation efficiency similar to that of the pilQ2 mutant. De-
spite their nonpiliated colony morphology, each of these three
mutants expressed the tfp, albeit at markedly reduced levels com-
pared to the parental strain. Many fewer cells expressed pili, and
mutant cells that possessed pili had fewer pili than individual wild-
type cells. However, no correlation was observed between the
numbers of pili produced by the mutants and their transforma-
tion efficiencies.
Analysis of class 2 mutants. The class 2 mutants were interest-
ing in that the strains appeared to have a PilQ phenotype identical
to that of the parental strains. Because these strains were nonpili-
ated by colony morphology, we suspected that the mutations af-
fected PilQ in a way that did not alter its migration on SDS-PAGE
or that they mapped to a different gene in the pilus-biosynthetic
pathway. Sequencing of the pilQ genes from two of the strains
revealed a complete absence of mutations. Because pilQ is the last
gene of a large operon (pilMNOPQ), we sequenced the genes up-
stream of pilQ, which revealed that the pilM genes from both
mutants contained a single-base insertion after codon 19 that al-
tered the reading frame of pilM. Analysis of additional class 2
mutants with pilN and pilO antibodies also revealed several mu-
tants with frameshift mutations in pilN.
To aid in subsequent analyses, we generated our own frame-
shift mutations in pilM, pilN, pilO, and pilP by digesting and filling
in a unique endogenous restriction site in plasmids harboring
each of the genes and then religating. These mutants were then
used to transform SZ3 to increased penicillin resistance. All of the
transformants were morphologically nonpiliated, as expected,
and appeared identical to the original frameshift mutation that
arose spontaneously. When these transformants were analyzed by
Western blotting with an antibody against PilQ, the levels of the
mature, SDS-resistant oligomer were similar to those in the pa-
rental strain, whereas there was a marked decrease in the levels of
the immature, SDS-labile form and its breakdown products (Fig.
3A). To examine whether the frameshift mutations could be com-
plemented, SZ3 was transformed with constructs that inserted an
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BA
C
FIG 2 Phenotypes of spontaneously arising pilQ mutants. (A) The MIC of penicillin G (MICpenG) was determined for strains harboring one of the 13 different
class 1 mutations in pilQ, as well as the parental strain (SZ3) and SZ3 pilQ2. The error bars indicate standard errors of the mean. (B) Transformation efficiencies
of the 13 class 1 pilQ-backcrossed mutants, SZ3, and SZ3 pilQ2. Each strain was transformed with a plasmid (pSY6) carrying a gyrB allele that confers resistance
to nalidixic acid (Nalr). SZ3 is a variant of strain RM11.2 that contains an inducible recA allele that allows IPTG control of pilin antigenic variation. Each of the
strains used in this experiment contained the same pilE sequence to minimize the influence of different PilE sequences on transformation efficiency. (C) Scanning
electron microscopy was used to examine SZ3 and three pilQ mutants with normal, ablated, and reduced transformation efficiencies (left to right).
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the gonococcal genome, followed by transformation with the ap-
propriate frameshift pil mutant (because the pil mutants prevent
subsequent transformation, this order of transformation was nec-
essary). However, the expression of the intact gene with IPTG had
no effect on penicillin resistance, suggesting that the effects of the
frameshift mutations were polar (data not shown).
Effects of in-frame pilM, pilN, pilO, and pilP mutations on
penicillin resistance, transformation efficiency, and expression
of the other Pil proteins. In-frame deletions in each of the four pil
genes were constructed and used to transform SZ3 or PR100 to
increased penicillin resistance, but no transformants could be se-
lected. This necessitated transforming PR100 with each of the
constructs and, after plating on GCB, analyzing colonies with a
nonpiliated morphology by PCR for the presence of the deletion.
When we examined the sequence-verified transformants, MICs
for strains harboring three of the four in-frame deletions (pilM,
pilN, and pilO) were identical to that for the parental strain (Fig.
4A), while the strain containing the pilP deletion displayed a small
increase in the MIC. These data again suggested that the original
frameshift mutations we isolated in the screen had a polar effect.
As previously established in Neisseria meningitidis, the in-frame
deletions of pilM, pilN, pilO, and pilP completely ablated transfor-
mation (37), which could be restored by expressing the corre-
sponding wild-type gene (Fig. 4B and C).
Polyclonal antibodies against purified PilM, PilN, and PilO
were generated and used to determine the effects of the in-frame
mutations on other Pil proteins. The pilM mutation had no no-
ticeable effect on expression of any of the other proteins (Fig. 5,
lanes 3 and 4 from the left). In contrast, deletion of pilN, pilO, or
pilP had profound effects on the stability of some or all of the other
proteins. For example, deletion of PilN caused the loss of PilO,
and deletion of PilO caused the loss of PilN (Fig. 5, lanes 5 to 8),
with levels of the other proteins similar to those in the parental
strain. These data are consistent with more recent reports showing
that the two proteins form a complex, and thus, we concluded that
loss of one of the two proteins results in the misfolding, instability,
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FIG 3 MICs of penicillin and levels of PilQ for strains containing pilM, pilN,
and pilO frameshift mutations. (A) The levels of PilQ in strains harboring
frameshift mutations in pilM, pilN, and pilO (parental strain, SZ3) were deter-
mined by Western blotting. (B) The MICs of penicillin for the different frame-
shift mutants transformed into PR100 were determined as described in Mate-
rials and Methods and compared to those of PR100 and PR100 harboring



















FIG 4 MICs of penicillin and transformation efficiencies for strains harboring in-frame deletions of pilM, pilN, pilO, and pilP. (A) In-frame deletions (IFD) of
pilM, pilN, pilO, and pilP were constructed and transformed into PR100, and the MIC of penicillin for each strain, together with PR100 and PR100 pilQ2, was
determined. The error bars indicate standard errors of the mean. (B) Effects on transformation efficiencies of PR100 with an in-frame deletion of pilM, pilN, pilO,
or pilP and of the corresponding complemented strains (indicated by a subscript c). (C) Western blots of PilM, PilN, PilO, and PilP showing the wild-type strain,
individual deletions, and the mutants complemented by expressing an IPTG-inducible allele of the deleted gene.
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or PilO caused only a minor decrease in the PilP levels, deletion of
PilP resulted in the loss of PilN and PilO (Fig. 5, lanes 9 and 10).
These data suggest that PilP acts to stabilize PilN and PilO but that
PilP is stable in the absence of PilN and PilO.
Analysis of the frameshift mutations with the different Pil
antibodies (data not shown) showed the same banding pattern for
PilM, PilN, PilO, and PilP that was observed with the in-frame
deletions (Fig. 5), suggesting that increases in the MIC of penicil-
lin were not due to changes in expression of these proteins. The
similarity of the banding patterns in the frameshift and in-frame
deletion mutants, together with the observation that in-frame de-
letions of these four Pil proteins had no effect on resistance levels,
indicated that the absence of any of the proteins was not respon-
sible for changes in antibiotic permeation. This conclusion fo-
cused our attention back on PilQ and on how the frameshift mu-
tations (e.g., pilMFS) result in nearly the same level of resistance to
penicillin as a complete deletion of the pilQ gene.
Effects of titration of PilQ levels on penicillin resistance and
transformation efficiency. To obtain direct evidence that levels of
PilQ determine gonococcal sensitivity to penicillin, we created a
strain with an IPTG-inducible, HA-tagged pilQ gene inserted into
the chromosome of PR100, using the integration vector pKH35,
to create PR100 pKH35-pilQHA. This strain was then transformed
with an insertionally inactivated pilQ construct to disrupt the en-
dogenous pilQ allele, yielding PR100 pKH35-pilQHA pilQ::. The
former strain expresses more PilQ than parental cells in the pres-
ence of IPTG, whereas the latter strain expresses PilQHA only fol-
lowing IPTG induction. We then used these two strains and the
parental strain PR100 to evaluate the effects of different levels of
PilQ expression on susceptibility to penicillin and transformation
efficiency. As expected, Western blots using both anti-HA and
anti-PilQ antibodies revealed that the levels of PilQHA in the
pKH35-pilQ strains varied with the amount of IPTG added (Fig.
6A) and that PR100 pKH35-pilQ produced higher levels of PilQ
than PR100 pKH35-pilQHA pilQ::.
The MICs of penicillin were determined for the three strains on
GCB-penicillin plates containing increasing amounts of IPTG
(Fig. 6B). As expected, the MIC of penicillin for PR100 did not
change with the different concentrations of IPTG. For PR100
pKH35-pilQHA, the MIC for penicillin in the presence of 0.01 mM
IPTG was identical to that of PR100, indicating a very low level of
pilQHA induction, but as the concentration of IPTG increased, the
MIC decreased below the level of the parental strain, strongly sug-
gesting that the higher levels of PilQ enhance permeation of pen-
icillin into the periplasm and increase susceptibility to the antibi-
otic. In contrast, the MIC of penicillin for PR100 pKH35-pilQHA
pilQ:: in the presence of 0.01 mM IPTG was similar to that for a
strain that produces no PilQ, but as the concentration of IPTG
increased, the MIC of penicillin decreased, so that at 1.0 mM
IPTG, it was identical to the MIC for PR100. These data strongly
support our hypothesis that penicillin gains entry to the periplasm
by diffusing through pores formed by PilQ.
We next examined the effects of manipulating levels of PilQ on
transformation efficiency. The transformation efficiency in PR100
pKH35-pilQHA pilQ:: was below the level of detection at 0.01
mM IPTG, consistent with the absence of PilQ determined by
Western blotting (Fig. 6A and C), but was essentially identical to
that in PR100 at 0.1 and 1.0 mM IPTG, concentrations at which
pilQ expression was similar to that in PR100. The transformation
efficiency of PR100 pKH35-pilQHA, which contained the endoge-
nous pilQ gene, was similar to that of PR100 at 0.01 mM IPTG and
increased by 10-fold as the concentration of IPTG increased.
Analysis of PilQ levels in wild-type versus frameshift mu-
tants. There are three forms of PilQ that can be observed on a
Western blot: (i) the mature, SDS-resistant multimer at the top of
the running gel; (ii) the immature, SDS-labile monomer (72 kDa);
and (iii) PilQ breakdown products. Theoretically, any (or all) of
these forms could be responsible for allowing diffusion of antibi-
otics into the periplasm. One observation that was consistent over
multiple blots was that the pilM frameshift mutation resulted in
decreased levels of all three forms of PilQ but most notably af-
fected the levels of the monomer and breakdown products (Fig.
3A). To examine the levels of the different PilQ forms in the pa-
rental strain versus the pilM frameshift mutant, we quantified the
amounts of PilQ multimer and monomer present in lysates of
wild-type and pilM mutant cells. Averaging over several blots with
multiple independently prepared samples, we found that the level
of the PilQ monomer in the pilM frameshift mutant was decreased
by 48% compared to that in the wild-type strain, whereas the level
of multimer in the frameshift mutant was decreased by only 26%
(Fig. 7), with the decrease in the monomer significantly different
from the decrease in the multimer (P  0.05). These data sug-
gested that the immature, SDS-labile form of PilQ (or its degra-
dation products), and not the mature multimer, might be the
entity responsible for forming the pores through which antibiotics
diffuse into the periplasm.
For the SDS-labile monomers of PilQ to be responsible for
antibiotic influx, they would likely need to assemble into imma-
ture oligomers (i.e., similar in size and structure to mature PilQ
oligomers but not yet SDS resistant) that form a pore in the outer
membrane. To investigate this possibility, PilQ proteins were de-
tergent extracted from membranes of FA19 and chromato-
graphed on Sephacryl S-500, and fractions were assessed for the
levels of the different forms of PilQ. As reported previously, the
SDS-resistant multimer eluted as a broad single peak centered at 1
































































FIG 5 Effects of in-frame deletions of pilM, pilN, pilO, and pilP on the stability
of the proteins encoded by other genes in the operon. The Western blots show
the effects of deletion of pilM, pilN, pilO, or pilP on the levels of other proteins
encoded by the pilMNOPQ operon relative to wild-type PR100 and the pilQ2
mutant.
Antibiotic Diffusion through Gonococcal PilQ Secretin
April 2015 Volume 197 Number 8 jb.asm.org 1315Journal of Bacteriology
peaks: a shoulder peak that coeluted at the same molecular mass as
the SDS-resistant PilQ oligomers and a large, broader peak that
eluted with a molecular mass of 350 kDa (Fig. 8) (23). These
large oligomers, like the SDS-resistant oligomer, could potentially
mediate both the diffusion of small molecules through their cen-
tral pore and the extrusion of the pilus through the outer mem-
brane.
Manipulation of PilW expression to regulate levels of the
SDS-resistant PilQ multimer. To further investigate the roles of
the different forms of PilQ in antibiotic permeation, we manipu-
lated levels of PilW, a protein required for formation of the SDS-
resistant PilQ multimer (37–39). We reasoned that if the SDS-
resistant multimer of PilQ was responsible for antibiotic influx,
then the absence of the oligomer should result in an increase in the
MIC of penicillin to a level similar to that of the pilQ2 mutant.
Therefore, we insertionally inactivated pilW with a kanamycin
resistance cassette, which resulted in complete conversion of the
SDS-resistant PilQ oligomer to the immature monomeric form on
SDS-PAGE (Fig. 9A). However, conversion of the multimeric
PilQ to the monomeric form on SDS-PAGE had no effect on pen-
icillin resistance (Fig. 9B), suggesting that the SDS-resistant mul-
timer is not the species that forms pores in the outer membrane
that allow diffusion of antibiotics into the periplasm. FA19 pilW::
kan cells demonstrated only a slight decrease in transformation
efficiency (Fig. 9C), consistent with our gel filtration data showing
that the SDS-labile species of PilQ that runs as a monomer on
SDS-PAGE can still oligomerize and form a pore through which
the pilus can extrude.
We next attempted to decrease the levels of SDS-labile PilQ
monomers by overexpressing PilW, which we hypothesized
would convert more of the monomers to the mature form. Two
additional inducible copies of pilW were inserted onto the chro-
mosome while leaving the endogenous pilW gene intact, and
Western blotting confirmed that PilW was indeed overexpressed
(Fig. 10A). However, there was no corresponding increase in the
PilQ multimer, and we did not observe a decrease in the PilQ
monomer compared to the PR100 parental strain (Fig. 10A).
Moreover, overexpression of PilW had essentially no effect on the
MIC of penicillin (Fig. 10B).


































FIG 6 Effects of different levels of PilQ on transformation efficiency and the MIC of penicillin. PR100 was transformed in a stepwise manner to insert an
IPTG-inducible copy of pilQHA at a transcriptionally silent locus on the gonococcal genome (PR100 pKH35-pilQHA). The endogenous copy of pilQ was
subsequently disrupted to create PR100 pKH35-pilQHA pilQ::. (A) Western blot showing the effects of 0.01, 0.1, and 1.0 mM IPTG on the expression of PilQ
in the strains containing an IPTG-inducible copy of pilQ. (B) The MICs of penicillin for the IPTG-inducible PilQ strains were determined in the presence of three
different concentrations of IPTG (0.01, 0.1, and 1.0 mM). The error bars indicate standard errors of the mean. (C) The transformation efficiencies of the
IPTG-inducible PilQ strains were determined in the presence of three different concentrations of IPTG (0.01, 0.1, and 1.0 mM). NT, not tested. The dotted line
represents the limit of detection.
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with a model in which an overabundance of PilQ subunits, only
some of which mature to the SDS-resistant multimer, associate to
form immature PilQ multimers that mediate antibiotic influx into
the cell. Thus, frameshift mutations in pilMNOP exert their polar
effects on penicillin resistance by decreasing the amounts of PilQ
monomers.
DISCUSSION
The contribution of PilQ to antibiotic susceptibility was first iden-
tified in a search for genes involved in high-level penicillin resis-
tance. A spontaneously arising penicillin-resistant mutation,
termed pilQ2, resulting from an amino acid change of Glu-666 to
Lys, interfered with the formation of SDS-resistant PilQ oligom-
ers; decreased transformation competency; and, in the presence of
other resistance determinants, conferred a 2- to 3-fold increase in
the MICs of penicillin and tetracycline (23). In this study, we
followed up on these initial observations by identifying additional
spontaneously arising mutations that increase the MIC of penicil-
lin. Surprisingly, in addition to expected mutations in pilQ, we
identified mutations in the genes upstream of pilQ in the pilM-
NOPQ operon that resulted in a resistance phenotype similar to
that of the pilQ2 mutant, but the increased resistance of these
mutants was due to polar effects on pilQ rather than the absence of
the upstream genes. To verify that PilQ expression levels can alter
sensitivity to penicillin, strains that allowed us to vary the level of
PilQ were generated, and we observed that the MIC of penicillin
was inversely proportional to the expression level of PilQ. These
data implicate PilQ in antibiotic susceptibility and suggest that as
the levels of PilQ increase, so does the formation of outer mem-
brane pores through which penicillin can access the periplasm.
We considered two models that were most likely to explain our
results. The first model, which is perhaps the most straightforward
and is the one we favored at the start of these experiments, was that
antibiotics gain entry to the periplasm through mature PilQ oli-
gomeric pores. This model is supported by the observation that
the total amount of PilQ is decreased in the frameshift mutants,
meaning that fewer pores that can allow the antibiotics to perme-
ate the outer membrane exist. However, the SDS-resistant oli-
gomer was the form of PilQ least affected by the frameshift muta-
tions, and recent evidence suggests that similar secretins have
mechanisms that allow them to close in vivo (28, 40, 41). In addi-
tion, deletion of pilW, the protein required for production of the
stable SDS-resistant PilQ multimer (37, 39), did not increase pen-
icillin resistance. Finally, if SDS-resistant oligomers were respon-
sible for antibiotic influx, there should have been a linear relation-
ship between the levels of the multimer and the MIC; however, the
levels of the PilQ oligomer in strains containing a PilM frameshift
mutation were decreased by only 26%, yet these strains had MICs
that were nearly identical to those of strains with a pilQ2 mutation
or PilQ deletion (Fig. 7 and 9 and data not shown). Taken to-
gether, these data were inconsistent with the model that the ma-
ture, SDS-resistant oligomer forms a pore for antibiotics and
other small molecules.
In contrast, our data are entirely consistent with the second
model, in which immature PilQ entities permit diffusion of anti-
biotics into the periplasm. This model is supported by experi-
ments showing that there is a much greater decrease in the PilQ

















FIG 7 Quantitative Western blot for PilQ in PR100 and PR100 pilMFS. (A)
Representative quantitative Western blot showing the effect of the pilM frame-
shift mutation on the expression of PilQ multimers and monomers. Anti-PilQ
antibody was detected with a Cy3-conjugated anti-rabbit secondary antibody
using a Typhoon fluorescence imager. (B) The levels of PilQ multimers and
monomers from 10 to 13 independent samples from 3 separate blots were
quantified using ImageQuant software, as described in Materials and Methods.
The mean decreases for the multimer and monomer in the pilMFS mutant
relative to the parental strain were 26% and 48%, respectively. *, P  0.05; **,
P  0.01; ****, P  0.0001. The error bars indicate standard errors of the mean.
FIG 8 Gel filtration of PilQ extracted from FA19 membranes. FA19 mem-
branes were extracted with 2% SB-10 and subjected to gel filtration on a Sep-
hacryl S-500 column as described in Materials and Methods. The eluted frac-
tions were assessed by SDS-PAGE and Western blotting for PilQ. The amounts
of PilQ multimer and monomer were quantified using QuantityOne software.
The arrows and molecular weights above the graph show the positions of
protein standards. (A portion of this graph was reprinted from reference 23
with permission of the publisher.)
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timer. This model also accounts for the absence of a resistant phe-
notype in a strain lacking PilW; when pilW is disrupted, the SDS-
resistant PilQ multimer is completely absent and looks similar to
the pilQ2 mutant by Western blotting, but without a correspond-
ing increase in antibiotic resistance. These observations, together
with gel filtration data on detergent extracts of gonococcal mem-
branes (Fig. 8) (23) demonstrating that a portion of monomeric
PilQ (by SDS-PAGE) exists in multimeric form, suggest that PilQ
subunits oligomerize to form immature, SDS-labile multimers
that allow antibiotic diffusion into the periplasm.
It is important to distinguish the effects of mutations in PilQ,
which both increase resistance and disrupt multimer formation,
from the effects of frameshift mutations in the upstream pilMNOP
genes, which also increase resistance but have only minor effects
on multimer formation. Previous data demonstrated that resis-
tance-conferring PilQ mutations do not prevent oligomerization
of PilQ subunits; instead, these mutations must affect the confor-
mation of the SDS-labile oligomer so that the pore is essentially
blocked, thereby preventing the diffusion of antibiotics. The ob-
servation that some class 1 PilQ mutants still undergo transforma-
tion suggests that some pilus strands are able to extrude through
the immature secretin, but based on our SEM results, this occurs
in only a small portion of the PilQ oligomers in the outer mem-
brane. In contrast, there are no mutations in PilQ that prevent
antibiotic diffusion in the frameshift mutations in pilMNOP; in-
stead, these mutations are polar and decrease the level of PilQ
monomers in the outer membrane, with the lower levels of PilQ
decreasing the mass action association of PilQ monomers to form
immature oligomeric complexes that we predict serve as a route of
entry of antibiotics.
For reasons that are not entirely clear, N. gonorrhoeae expresses
an overabundance of PilQ subunits, only some of which become
mature multimers. Our model predicts that there is a threshold
level at which immature subunits begin to associate and form
pores, which is consistent with the nonlinearity observed between
resistance and PilQ levels. Thus, if a threshold level of PilQ mono-
mers is required to promote formation of immature complexes by
mass action, then decreasing PilQ expression by 30% overall
































FIG 10 Effects of overexpression of PilW on the levels of PilQ multimer and
the MIC of penicillin. Wild-type cells were transformed with a proAB-targeted
expression construct (pUC18K-proAB-Q19e) containing pilW under the con-
trol of the tac promoter. The resulting strain was also transformed with the
plasmid pKH35-pilW, which introduced an additional copy of the IPTG-in-
ducible pilW gene into the gonococcal genome. The resulting strain contained
the native pilW gene, as well as two IPTG-inducible copies in separate regions
of the chromosome. (A) Western blot showing the effect of expressing native
PilW and IPTG-inducible PilW at various concentrations of IPTG compared
to wild-type cells, the pilQ2 mutant, the pilM frameshift mutant, and the pilW::
kan mutant. (B) Effects of two IPTG-inducible copies of pilW on the MIC of























FIG 9 Effects of deletion of PilW on the levels of PilQ multimer, the MIC of penicillin, and transformation efficiency. (A) Western blot using a fluorescent
secondary antibody to PilW showing the impact of insertional inactivation of pilW on the PilQ multimer/monomer ratio relative to wild-type cells, the pilQ2
mutant, and the pilM frameshift mutant. (B and C) Effects of disruption of pilW on the MIC of penicillin (B) and transformation efficiency (C). The error bars
indicate standard errors of the mean.
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tance. Our studies manipulating the levels of PilQ were entirely
consistent with this hypothesis. Unfortunately, efforts to decrease
the levels of SDS-labile monomers by overexpressing the PilW
protein involved in maturing PilQ complexes (37, 39), which
would be a direct test of this model, were unsuccessful.
We cannot rule out the possibility that proteolytic fragments of
immature PilQ subunits, which are observed in Western blots of
both N. gonorrhoeae and Pseudomonas aeruginosa membranes
(42), are the entities that form pores. Proteolysis of the N-terminal
region of PilQ that leaves the C-terminal beta-barrel region intact
could in theory result in the formation of pores lacking a “plug”
that full-length, loosely associated complexes possess. However,
the difficulties of preventing proteolysis of PilQ, particularly when
oligomer formation is impeded or eliminated, precluded us from
fully examining this possibility, and thus, we cannot eliminate the
possibility that proteolytic fragments of PilQ play a part in antibi-
otic entry.
Thus far, PilQ mutants have not been found in clinical isolates;
indeed, nearly all clinical isolates are piliated at the time of isola-
tion (32, 43). Whiley et al. examined the pilQ sequences of 63 N.
gonorrhoeae clinical isolates and found that mutations in PilQ did
not contribute to decreased susceptibility to cefixime or ceftriax-
one (44). Because all of the mutations that we identified in PilQ or
upstream in PilM, PilN, PilO, or PilP that increase resistance also
decreased or disrupted piliation, it appears likely that antibiotic-
resistant mutants that arise during the course of infection and
antibiotic treatment would be unfit and outcompeted by other
piliated strains. However, experimental infections of male volun-
teers using a nonpiliated variant of F62 or an FA1090 pilE mutant
showed that the pilus was not required for infection, although the
symptoms were less severe in the infections with the nonpiliated
variant (45). Both of these strains possessed a normal copy of the
pilQ gene, so it remains possible that PilQ is required for infection
even in the absence of pili. Furthermore, the role of the pilus in
disseminated gonococcal infections has not been examined, and it
is possible that nonpiliated antibiotic-resistant mutants could
cause serious complications.
Although the pilMNOPQ mutations described in this paper
may not be clinically relevant, our comparisons of the frameshift
and in-frame deletion mutants provide insight into the biogenesis
of type IV pili, a complex process that has not yet been entirely
elucidated. A screen of N. meningitidis pilus-deficient mutants
had previously identified all five genes in the pilMNOPQ operon
as essential for pilus assembly (37), and experiments performed in
P. aeruginosa have shown that the proteins encoded by these genes
form an inner membrane complex (37, 42, 46–48). Ayers et al.
(42) showed that in P. aeruginosa, mutation of PilN resulted in the
loss of PilO expression, and vice versa, consistent with our results
and those of others (46) showing that PilN and PilO from P.
aeruginosa form heterodimers. Ayers et al. also showed that dele-
tion of PilM resulted in the complete loss of PilN, PilO, and PilP
expression, whereas deletion of PilN, PilO, and PilP had no effect
on PilM levels. In contrast, we showed that deletion of gonococcal
PilM had no effect on PilN, PilO, and PilP expression. Another
difference between our results and those from P. aeruginosa is that
deletion of either PilN or PilO in N. gonorrhoeae had no effect on
PilP expression, whereas in P. aeruginosa, deletion of PilP was
reported to result in the loss of PilN and PilO. Moreover, deletion
of any of the first four genes in the pilMNOPQ operon in P. aerugi-
nosa decreased levels of PilQ (42), whereas we saw no difference in
PilQ expression in strains with in-frame deletions of PilM, PilN,
PilO, or PilP. The differences between the two organisms are sur-
prising, given that the gonococcal proteins are 50% identical to
their corresponding pseudomonal counterparts.
Despite these differences, our results are generally consistent
with models for PilQ complexes proposed in both P. aeruginosa
and N. meningitidis. These models have the cytoplasmic protein
PilM interacting with the N terminus of the inner membrane pro-
tein PilN, PilN interacting with PilO, and PilP interacting with
PilN to form PilNOP heterotrimers (42, 46–49). While relevant
for pilus assembly, none of the studies on the complex formed by
the first 4 proteins encoded by the pilMNOPQ operon explain how
frameshift mutations upstream of pilQ affect antibiotic suscepti-
bility. Also to be considered is the phenotype of a previously de-
scribed F595L mutation in pilQ (pilQ1), which confers increased
antibiotic susceptibility. The pilQ1 mutation was isolated as a
spontaneous suppressor mutation that allowed a strain of FA1090
with a deletion in the HpuA hemoglobin receptor protein to again
utilize hemoglobin as the sole source of iron, likely by allowing
free heme to diffuse into the cell (35). The different effects of these
pilQ mutations on antibiotic susceptibility highlight the role of
PilQ in membrane permeability.
Although all of the class 1 PilQ mutations increased the MIC of
penicillin to the same level, the effects of the different mutations
on transformation efficiency varied dramatically. For example, of
the 13 class 1 mutations, 9 had transformation efficiencies similar
to those of the wild-type strain or the pilQ2 mutant and 4 had
transformation efficiencies that were below the limit of detection
(Fig. 2B). Thus, even though the strains harboring the 13 class 1
PilQ mutants appear identical by Western blotting and MIC, the
function of their type IV pili is affected in different ways. Surpris-
ingly, we observed type IV pili by SEM (albeit quite sparsely) for
strains harboring three class 1 PilQ mutants that conferred nor-
mal, decreased, and ablated tranformation efficiencies. Since the
capacity to undergo transformation depends on the ability of the
tfp to extend and retract through the PilQ secretin, the PilQ in
the 9 transformation-competent mutants must be able to form
outer membrane pores, even though SDS-resistant oligomers are
not observed by SDS-PAGE. This further suggests that pores can
be formed through interactions of PilQ complexes that are not
fully mature.
In conclusion, this study identifies immature PilQ complexes,
and not SDS-resistant PilQ multimer complexes, as the entities
involved in forming pores in the outer membrane of N. gonor-
rhoeae and allowing permeation of antibiotics into the periplasm.
Although not yet observed clinically, it remains possible that mu-
tations that block permeation but allow nearly normal piliation
will arise in the future and provide additional resistance to antibi-
otics in strains that have decreased membrane permeability.
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